Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frequent hitters: nuisance artifacts in high-throughput screening
Ziyi Yang, Jun-Hong He, Aiping Lü, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 4, pp. 657-667
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
Guo‐Li Xiong, Zhenhua Wu, Jiacai Yi, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. W1, pp. W5-W14
Open Access | Times Cited: 1601
ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support
Li Fu, Shaohua Shi, Jiacai Yi, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W422-W431
Open Access | Times Cited: 112
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors
Rachel H. Clare, Charlotte A. Dawson, Adam Westhorpe, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
DrugFlow: An AI-Driven One-Stop Platform for Innovative Drug Discovery
Chao Shen, Jianfei Song, Chang‐Yu Hsieh, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 14, pp. 5381-5391
Closed Access | Times Cited: 7
Evolution of Novartis’ Small Molecule Screening Deck Design
Ansgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14425-14447
Closed Access | Times Cited: 58
Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery
Purvashi Pasrija, Prakash Jha, Pruthvi Upadhyaya, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 20, pp. 1692-1727
Closed Access | Times Cited: 28
Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications
Ziyi Yang, Shaohua Shi, Li Fu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4361-4377
Closed Access | Times Cited: 15
Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX
Michael Hetmann, Christine Langner, Vedat Durmaz, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Dissecting the structural heterogeneity of proteins by native mass spectrometry
Deseree J. Reid, Stephanie Thibert, Mowei Zhou
Protein Science (2023) Vol. 32, Iss. 4
Open Access | Times Cited: 12
Scopy: an integrated negative design python library for desirable HTS/VS database design
Ziyi Yang, Zhijiang Yang, Aiping Lü, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 32
Preparing (Metalla)carboranes for Nanomedicine
Marta Gozzi, Benedikt Schwarze, Evamarie Hey‐Hawkins
ChemMedChem (2021) Vol. 16, Iss. 10, pp. 1533-1565
Open Access | Times Cited: 30
PharmSD: A novel AI-based computational platform for solid dispersion formulation design
Jie Dong, Hanlu Gao, Defang Ouyang
International Journal of Pharmaceutics (2021) Vol. 604, pp. 120705-120705
Closed Access | Times Cited: 29
SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
Aixin Li, Kaitao Zhao, Bei Zhang, et al.
Journal of Virology (2021) Vol. 95, Iss. 17
Open Access | Times Cited: 28
The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes
Douglas B. Kell
Molecules (2021) Vol. 26, Iss. 18, pp. 5629-5629
Open Access | Times Cited: 28
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale
Michael A. McCoy, Dominique Spicer, Neil J. Wells, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7246-7261
Open Access | Times Cited: 20
Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds
Matic Proj, Damijan Knez, Izidor Sosič, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1733-1742
Open Access | Times Cited: 18
Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts
Ziyi Yang, Zhijiang Yang, Jun-Hong He, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 6, pp. 1353-1358
Closed Access | Times Cited: 24
Acoustic Mist Ionization-Mass Spectrometry: A Comparison to Conventional High-Throughput Screening and Compound Profiling Platforms
Arseniy M. Belov, Joseph Kozole, Mark F. Bean, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 20, pp. 13847-13854
Closed Access | Times Cited: 24
Structural Analysis and Identification of False Positive Hits in Luciferase-Based Assays
Ziyi Yang, Jie Dong, Zhijiang Yang, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 4, pp. 2031-2043
Closed Access | Times Cited: 23
Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases
Christophe Müller, Obdulia Rabal, Constantino Diaz Gonzalez
Methods in molecular biology (2021), pp. 383-407
Closed Access | Times Cited: 20
Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds
Vinícius M. Alves, Adam Yasgar, James Wellnitz, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 12828-12839
Closed Access | Times Cited: 5
Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery
Maximilian G. Schuh, Davide Boldini, Stephan A. Sieber
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 12, pp. 4640-4650
Open Access | Times Cited: 1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? – A Teacher's Perspective
Philipp Klahn
ChemMedChem (2024)
Open Access | Times Cited: 1
Using NMR Spectroscopy in the Fragment‐Based Drug Discovery of Small‐Molecule Anticancer Targeted Therapies
Benjamín Diethelm‐Varela
ChemMedChem (2020) Vol. 16, Iss. 5, pp. 725-742
Closed Access | Times Cited: 15
Drug discovery and chemical probing inDrosophila
Cassandra Millet-Boureima, Susannah Selber‐Hnatiw, Chiara Gamberi
Genome (2020) Vol. 64, Iss. 2, pp. 147-159
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top